Header Logo

Connection

SUSAN BLANEY to Thionucleotides

Back to Details
This is a "connection" page, showing publications SUSAN BLANEY has written about Thionucleotides.
SUSAN BLANEY
Connection Strength
0.071
Thionucleotides
  1. Phase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children's Oncology Group Study. J Clin Oncol. 2007 Apr 20; 25(12):1512-8.
    View in: PubMed
    Score: 0.071
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.